Results 181 to 190 of about 26,568 (229)
Ketoconazole induced papilledema [PDF]
Acta Ophthalmologica, 1993 Abstract Ketoconazole was administered in a case of hirsutismus over a period of 4 months with high doses of 800 mg/day, and bilateral papilledema developed. After cessation of the drug the condition disappeared. As far as we know this is the first reported papilledema complication due to Ketoconazole.
AKBATUR, H +4 more
openaire +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medical Journal of Australia, 1983
The treatment of most fungal infections is difficult, at best. Antifungal therapy is complicated by the development of resistant organisms and by the toxicity of many agents. Ketoconazole, an orally active imidazole derivative, has been approved by the Food and Drug Administration for the treatment of candidiasis, chronic mucocutaneous candidiasis ...
A L, Hume, T M, Kerkering
+6 more sources
The treatment of most fungal infections is difficult, at best. Antifungal therapy is complicated by the development of resistant organisms and by the toxicity of many agents. Ketoconazole, an orally active imidazole derivative, has been approved by the Food and Drug Administration for the treatment of candidiasis, chronic mucocutaneous candidiasis ...
A L, Hume, T M, Kerkering
+6 more sources
Ketoconazole and the Antifungals
Otolaryngology–Head and Neck Surgery, 1985A new antifungal agent, ketoconazole, has been added to the drugs available for the treatment of fungal infections. Ketoconazole has been shown to be effective in the treatment of mucocutaneous candidiasis with a reported 97% positive response rate. This drug may be administered orally to outpatients with a low risk of toxicity.
openaire +2 more sources